U.S. Stock Market News | Stocks related to weight loss drugs fell, Novo Nordisk dropped more than 4%
I'm PortAI, I can summarize articles.
周三，减肥药概念相关股下跌，截至发稿，诺和诺德跌超 4%，礼来跌 1.6%，辉瑞跌 0.34%。哈佛大学附属医院 Massachusetts Eye and Ear 医生们的分析结果显示，诺和诺德畅销的减肥药 Ozempic 和 Wegovy 似乎与患上罕见视觉功能丧失的风险上升有关。针对病历的研究结果显示，相比那些使用其他品牌减肥药的人，使用诺和诺德减肥药来减肥的患者们患上非动脉性前部缺血性视神经病变 (NAION) 的可能性要高出七倍。
智通财经 APP 获悉，周三，减肥药概念相关股下跌，截至发稿，诺和诺德 (NVO.US) 跌超 4%，礼来 (LLY.US) 跌 1.6%，辉瑞 (PFE.US) 跌 0.34%。哈佛大学附属医院 Massachusetts Eye and Ear 医生们的分析结果显示，诺和诺德畅销的减肥药 Ozempic 和 Wegovy 似乎与患上罕见视觉功能丧失的风险上升有关。针对病历的研究结果显示，相比那些使用其他品牌减肥药的人，使用诺和诺德减肥药来减肥的患者们患上非动脉性前部缺血性视神经病变 (NAION) 的可能性要高出七倍。
Source: 智通财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments